Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children

Area of Science:

• Pediatric infectious diseases
• Immunology
• Cardiology

Background:

• Multisystem inflammatory syndrome in children (MIS-C) is a novel clinical entity.
• It is a late complication of SARS-CoV-2 infection.
• Understanding its immunopathogenesis is crucial.

Purpose of the Study:

• To highlight MIS-C as a new clinical entity.
• To review progress in understanding MIS-C immunopathogenesis.
• To compare and contrast MIS-C with Kawasaki disease (KD).

Main Methods:

• Review of recent studies on MIS-C and KD.
• Analysis of clinical and immunological features.
• Comparison of disease mechanisms and outcomes.

Main Results:

• MIS-C exhibits significant immune dysregulation, including T cell abnormalities and elevated inflammatory markers.
• MIS-C and KD share clinical similarities but are distinct entities.
• Myocardial dysfunction in MIS-C is typically transient, unlike the lifelong coronary sequelae in KD.

Conclusions:

• MIS-C is a distinct condition from KD, characterized by immune activation post-SARS-CoV-2.
• While cardiac involvement occurs in MIS-C, it is generally reversible.
• Supportive and anti-inflammatory treatments aid recovery, and vaccines may prevent MIS-C.